Opendata, web and dolomites

BestTreat SIGNED

BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BestTreat project word cloud

Explore the words cloud of the BestTreat project. It provides you a very rough idea of what is the project "BestTreat" about.

microbial    metabolism    fosters    molecular    therapeutics    sectoral    competencies    academic    education    network    human    young    treatments    microbiome    metabolically    decennium    therapeutic    tissue    skills    qualified    overcomes    identification    samples    complemented    risk    trains    transferable    screening    genome    live    prediction    training    interdisciplinary    signatures    scientists    throughput    computer    organisms    hands    drug    educate    industry    besttreat    translate    discovery    skilled    companies    types    sustainable    biotherapeutics    forming    esrs    life    links    sciences    technologies    nafld    optimally    ultimately    entrepreneurial    medicine    disciplinary    train    beneficial    combine    metabolic    generation    biology    leads    upcoming    cell    modern    therapies    15    barriers    monitoring    cross    uncover    inter    questions    multidisciplinary    establishing    medical    complete    clinical    microbiology    improvements    world    characterization    bioinformatics    science    functional    model    data   

Project "BestTreat" data sheet

The following table provides information about the project.

Coordinator
LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT 

Organization address
address: BEUTENBERG STRASSE 11A
city: JENA
postcode: 7745
website: http://www2.hki-jena.de/rz/hki_i00.htm

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 4˙134˙155 €
 EC max contribution 4˙134˙155 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT DE (JENA) coordinator 758˙365.00
2    ITA-SUOMEN YLIOPISTO FI (KUOPIO) participant 842˙417.00
3    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) participant 595˙044.00
4    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 531˙239.00
5    RIJKSUNIVERSITEIT GRONINGEN NL (GRONINGEN) participant 531˙239.00
6    CHR. HANSEN A/S DK (HOERSHOLM) participant 297˙522.00
7    CLINICAL-MICROBIOMICS AS DK (KOBENHAVN) participant 297˙522.00
8    AFEKTA TECHNOLOGIES LTD FI (SIILINJARVI) participant 280˙805.00
9    BIOFACTION KG AT (WIEN) partner 0.00
10    BRAVAD PRODUCTION APS DK (KOBENHAVN) partner 0.00
11    FRIEDRICH-SCHILLER-UNIVERSITAT JENA DE (JENA) partner 0.00
12    GUBRA APS DK (HORSHOLM) partner 0.00
13    SHANGHAI SIXTH PEOPLE'S HOSPITAL CN (SHANGHAI) partner 0.00
14    UDATHA DASARADHI SE (OSLO) partner 0.00

Map

 Project objective

BestTreat fosters education of ESRs in a project to uncover microbiome signatures for risk prediction and monitoring of NAFLD and to contribute to the development of therapeutic treatments based on metabolically beneficial microbial consortia. It trains 15 ESRs at world-leading academic institutions and companies, thus forming strong interdisciplinary links between industry, life and medical sciences, and end-users. BestTreat aims to train a new generation of highly qualified ESRs with entrepreneurial competencies in modern Life Sciences through state-of-the-art research projects. The projects focus on the identification and functional characterization of microbial consortia that contribute to metabolic control, and the application of this knowledge to develop novel leads for drug discovery and therapies for NAFLD. The new field on microbiome based therapeutics requires highly skilled scientists with interdisciplinary knowledge on medicine, systems biology and computer science, as well as hands-on experience with several types of tissue samples and model organisms that can optimally translate their research findings into sustainable improvements in clinical practice. BestTreat overcomes current barriers by establishing a strong, multidisciplinary and inter-sectoral training network, developing technologies tailored to solve key questions in human metabolism, microbiology and bioinformatics. The BestTreat programme will exploit recent developments in high-throughput and genome-wide screening technologies, combine these with modern molecular cell biology and systems biology approaches and ultimately translate the data into new leads for the discovery of live biotherapeutics. This specific cross-disciplinary training program will educate young scientists to the next level needed to advance this research field for the upcoming decennium. The training programme will be complemented with a complete set of transferable skills.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BESTTREAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BESTTREAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More